A gap between total prostate-specific antigen and the sum of free prostate-specific antigen plus alpha1-antichymotrypsin-prostate- specific antigen in patients with prostate carcinoma but not in those with benign prostate hyperplasia

Clin Chem. 1999 Mar;45(3):422-4.

Authors

K Jung¹, B Brux, A Knäbich, M Lein, P Sinha, D Schnorr, S A Loening

Affiliation

¹ Department of Urology, University Hospital Charité, Humboldt University Berlin, Germany. klaus.jung@charite.de

PMID: 10053050

No abstract available

Publication types

Clinical Trial
Comparative Study
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Aged, 80 and over
Humans
Male
Middle Aged
Prostate-Specific Antigen / blood*
Prostate-Specific Antigen / metabolism
Prostatic Hyperplasia / blood*
Prostatic Neoplasms / blood*
alpha 1-Antichymotrypsin / blood*
alpha 1-Antichymotrypsin / metabolism

Substances

alpha 1-Antichymotrypsin
Prostate-Specific Antigen